Pilot Study of the eHealth Application (CAPABLE-IT)

  • STATUS
    Recruiting
  • participants needed
    30
  • sponsor
    Istituti Clinici Scientifici Maugeri SpA
Send
Updated on 8 December 2023
See if I qualify

Summary

The purpose of the CAPABLE study is to compare health-related quality of life in renal cell carcinoma patients who use or do not use a mobile-based application to monitor adverse events for cancer treatment at home. As secondary objectives, the study investigates the usability of the system and its generalizability to other cancer types

Description

The study is designed as a prospectively enrolling, quasi-experimental cohort study in cancer patients, eligible for systemic treatment.
The CAPABLE cohort will receive the smartphone application and a multi-sensorial smartwatch (ASUS VivoWatch 5 HC-B05). Patients will be asked to use the system for at least 6 months after enrollment. If, after 6 months, a patient wants to keep using the system, he will be allowed to do so, until the end of the study. Questionnaires on health-related quality of life will be administered to the patients on baseline (T0) and every three months (T1 and T2). Lost to follow-up data will be included in intention-to-treat analysis. Qualitative and quantitative user experience studies will be done at enrollment, after 3 months and at the end of the follow-up period with the CAPABLE system. Results of this interventional study will be compared with a control cohort consisting of renal cell carcinoma patients, recruited in 2021 with the same inclusion criteria as this study population, but receiving standard care (ICSM CE number 2546, dated 13/04/2021 and amended on 09/02/2022).

Details
Condition Renal Cell Carcinoma Metastatic, Breast Cancer, Head and Neck Cancer, Thyroid Cancer, Ovary Cancer, Lung Cancer, Stomach Cancer
Age 18years or above
Treatment CAPABLE cohort
Clinical Study IdentifierNCT06161233
SponsorIstituti Clinici Scientifici Maugeri SpA
Last Modified on8 December 2023

Eligibility

 Yes No Not Sure

Inclusion Criteria

Adults (age >=18 years)
Sufficient understanding of the Italian language
Patients or their caregiver (upon patient's consent) can use a smartphone
Histologically or cytologically confirmed diagnosis of RCC, lung, breast, thyroid o head and neck cancer
Candidate to systemic treatment (targeted agents, immune checkpoint inhibitors, or a combination of the two)
Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 at the start of the treatment

Exclusion Criteria

Recruitment and consent denial
Not able of understanding and complying with the protocol requirements (including basic technological abilities)
Given the fact that each subject involved in the clinical study must be able to understand and sign the informed consent presented by the researcher, lack of this capability represents a specific exclusion criterion in the study protocol
Clear my responses
Read more

How to participate?

Step 1 Connect with a study center
Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Other language

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.